Invention Grant
US08236836B2 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
有权
包含至少一种用于抑制朗格汉斯细胞迁移的恶唑啉的组合物及其用途
- Patent Title: Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
- Patent Title (中): 包含至少一种用于抑制朗格汉斯细胞迁移的恶唑啉的组合物及其用途
-
Application No.: US10499976Application Date: 2002-12-27
-
Publication No.: US08236836B2Publication Date: 2012-08-07
- Inventor: Philippe Msika , Nathalie Piccardi , Antoine Piccirilli
- Applicant: Philippe Msika , Nathalie Piccardi , Antoine Piccirilli
- Applicant Address: FR Courbevoie
- Assignee: Laboratoires Expanscience
- Current Assignee: Laboratoires Expanscience
- Current Assignee Address: FR Courbevoie
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR0116917 20011227
- International Application: PCT/FR02/04583 WO 20021227
- International Announcement: WO03/055463 WO 20030710
- Main IPC: A61K31/42
- IPC: A61K31/42

Abstract:
The invention concerns a composition containing at least an oxazolin, optionally combined with at least a compound such as a metalloprotease inhibitor, a PKC inhibitor, an anti-inflammatory agent, a soothing agent, an immunosuppressor, an ion chelating agent, an alkanolamide, an oxazolidinone and a carbamic acid derivative. The invention also concerns the use of such a composition as medicine, in particular for preventing or treating skin pathologies of allergic and/or inflammatory and/or irritative origin or resulting from a danger signal. The invention further concerns a method for cosmetic treatment of sensitive, irritated, intolerant, allergy-prone, ageing skin and/or mucosa exhibiting skin barrier disorder, or exhibiting non-pathological immunologic imbalance, which consists in applying such composition on the skin and/or mucosa.
Public/Granted literature
- US20050075380A1 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof Public/Granted day:2005-04-07
Information query